| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $249.4M | +14.6% |
| Cost of Revenue | $187.6M | +18.2% |
| Gross Profit | $61.8M | +4.9% |
| R&D Expense | $55.0M | +52.8% |
| SG&A Expense | $59.6M | +12.0% |
| Operating Income | -$70.9M | -71.5% |
| Pre-tax Income | -$186.7M | -233.2% |
| Income Tax | $2K | -77.8% |
| Net Income | -$186.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $67.4M | +48.6% |
| Accounts Receivable | $116.8M | +143.0% |
| Inventory | $88.1M | +38.0% |
| Current Assets | $301.3M | +74.5% |
| Total Assets | $547.0M | +40.6% |
| Current Liabilities | $170.1M | +82.2% |
| Long-term Debt | $26.7M | +15.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$69.5M | -776.9% |
| Capital Expenditures | $43.4M | +378.1% |
| Investing Cash Flow | -$50.7M | -243.5% |
| Financing Cash Flow | $142.2M | +250.4% |
| Free Cash Flow | -$112.9M | -564.0% |
| -233.2% |
| EPS (Basic) | -$4.50 | -157.1% |
| EPS (Diluted) | -$4.50 | -157.1% |
| Total Liabilities |
| $317.9M |
| +82.4% |
| Stockholders' Equity | $229.1M | +6.6% |